Amgen obesity drug on hold; Regeneron sets first dividend
Today, a brief rundown of news involving Amgen and Regeneron, as well as updates from Valneva, Turnstone Biologics and AdvanCell that you might have missed. The Food and Drug Administration has put an obesity study run by Amgen on clinical hold, the …